However, early detection of HE4 variants is more convenient in EC compared to ovarian or other types of cancer given that tumor cells can be collected non-invasively in menses or vaginal secretions by the use of pap smear-like devices or tampons [52]. This evidence concerns the gene WFDC2 and neoplasm.